[PLX] YoY Quarter Result on 30-Sep-2015 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- 24.67%
YoY- 52.31%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Revenue 663 7,526 4,670 5,846 3,707 3,359 5,390 -29.46%
PBT -15,544 -11,437 -7,290 -3,820 -8,010 -5,747 -5,479 18.97%
Tax 230 8 268 17 49 0 -81 -
NP -15,544 -11,437 -7,290 -3,820 -8,010 -5,747 -5,479 18.97%
Tax Rate - - - - - - - -
Total Cost 16,207 18,963 11,960 9,666 11,717 9,106 10,869 6.88%
Ratio Analysis
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
NP Margin -2,344.49 -151.97 -156.10 -65.34 -216.08 -171.09 -101.65 68.67%
Per Share
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
EPS -1.05 -0.86 -0.07 -0.04 -0.09 -0.06 -0.06 61.09%
EPS Diluted -1.05 -0.86 -0.07 -0.04 -0.09 -0.06 -0.06 61.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.